Cargando…

Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study

PURPOSE: Due to conflicting scientific evidence for an increased risk of dementia by intake of proton pump inhibitors (PPIs), this study investigates associations between PPI use and brain volumes, estimated brain age, and cognitive function in the general population. METHODS: Two surveys of the pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Nayeon, Frenzel, Stefan, Wittfeld, Katharina, Bülow, Robin, Völzke, Henry, Lerch, Markus M., Chenot, Jean-Francois, Schminke, Ulf, Nolde, Michael, Amann, Ute, Meisinger, Christa, Linseisen, Jakob, Baumeister, Sebastian E., Grabe, Hans Jörgen, Rückert-Eheberg, Ina-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184524/ https://www.ncbi.nlm.nih.gov/pubmed/33442768 http://dx.doi.org/10.1007/s00228-020-03068-8

Ejemplares similares

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
por: Rückert-Eheberg, Ina-Maria, et al.
Publicado: (2021)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Pattern of asthma medication use among children from a large urban center in Brazil
por: Santos, Djanilson Barbosa, et al.
Publicado: (2011)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Medication errors in the Middle East countries: A systematic review of the literature
por: Alsulami, Zayed, et al.
Publicado: (2012)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA)
por: Galvin, Rose, et al.
Publicado: (2014)

Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study
por: Bakken, Marit Stordal, et al.
Publicado: (2014)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
por: Reppe, Linda Amundstuen, et al.
Publicado: (2014)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
por: von Jeinsen, Beatrice K. J. G., et al.
Publicado: (2013)

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries
por: Renom-Guiteras, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ullhc49dbnmccvai4fj68v2ni